Zeluvalimab
Zeluvalimab (AMG-404) is a monoclonal antibody targeting the PD-1 receptor that can be used for the research of cancer[1].
Product Specifications
CAS Number
2315361-37-4
Product Name Alternative
AMG-404
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zeluvalimab.html
Purity
96.84
Solubility
H2O
Smiles
[Zeluvalimab]
Molecular Weight
(144.15 kDa)
References & Citations
[1]Price T J, et al. 142P Updated results from a phase I, open-label, multicenter, first-in-human study of AMG 404, a checkpoint inhibitor, in patients with advanced solid tumors. Annals of Oncology, 2021, 32: S1440-S1442.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D346800-250MG 250 mg
2,2-Dibromo-1-(3-chlorophenyl)propan-1-one
Sign In for Pricing
View Details 
LY400718 100 µg
HB EGF (HBEGF) (NM_001945) Human Over-expression Lysate
Sign In for Pricing
View Details 